New on Sports Illustrated: Is This As Good As It Gets for DeAndre Ayton? Not Likely
DeAndre Ayton's star turn has been impressive—but it's also forcing us to reconsider his ceiling. View the original article to see embedded media. Welcome to the Morning Shootaround, where every weekday you’ll get a fresh, topical column from one of SI.com ’s NBA writers: Howard Beck on Mondays, Chris Mannix on Tuesdays, Michael Pina on Wednesdays, Chris Herring on Thursdays and Rohan Nadkarni on Fridays. About a week before Christmas in 2019, Deandre Ayton was late to a game at Staples Center against the Clippers. It was his first in nearly two months, thanks to a 25-game suspension handed down by the NBA after Ayton violated its drug policy by testing positive for a banned diuretic. In the aftermath, Suns general manager James Jones issued the type of self-condemning statement that teams rarely make toward one of their own building blocks, writing: “This does not uphold the standards and principles we have set for the team.” Ayton was apologetic and sincere addressin